Loader

Please wait...

Canadian Pharmacists Association
Canadian Pharmacists Association
Share
Facebook Share
Twitter Share
LinkedIn Share
Google Plus Share
Email Share

Hypertension Care

Benefits of pharmacist care in hypertension management in Canada

While there is good evidence available for the health benefits of pharmacist intervention in hypertension management, there has been a lack of research done on the economic value of this type of intervention, particularly in Canada.

A new study published in the Canadian Pharmacists Journal, shows that comprehensive long-term pharmacist care for Canadians with hypertension, including patient education and prescribing, improves health outcomes and will save money for Canada’s cash-strapped health care system. Projected cost savings would be more than $15.7 billion if full scope pharmacist care were administered to the full eligible population in Canada.

The peer-reviewed study looked at alternatives to usual hypertension care, including full scope pharmacist care—making full use of pharmacists’ scope of skills, including prescribing. The analysis shows a real and significant benefit from pharmacist care both in terms of cost savings and health benefits when compared to usual care.

A conversation with the study's authors

 

The model presented in the report has been set up as an interactive tool that allows users to explore changes in economic and health impact under different timeframes and health scenarios:

 

Reports and Studies

CPhA Statements

Pharmacist care for patients with hypertension would save Canada’s health care system more than $15.7 billion
March 29, 2017 – First study of its kind highlights significant economic impact of pharmacist care in hypertension management